Groundbreaking study shows monocytes migrate to brain’s emotional centers during stress

Researchers report a mechanism wherein peripheral immune factors could impact central nervous system (CNS) function and behavior under stress.

Cybin Scores Breakthrough Therapy Designation for Deuterated Psilocybin Analog in MDD, Shares 4-Month Data – Psychedelic Alpha

Today, psychedelic drug developer Cybin announced that it has received breakthrough therapy designation for CYB003, its deuterated psilocybin analog candidate under development for major depressive

March 13, 2024

Does more education reshape your brain?

Researchers found no long-term brain structure changes from an extra year of compulsory education, challenging theories about education’s impact on neural development.

November 11, 2024

EC approves TECVAYLI’s reduced dosage for multiple myeloma

Janssen’s Teclistamab is a bispecific antibody directed at B-cell maturation antigen on multiple myeloma cells. Credit: Vysotsky / commons.wikimedia.org. The European Commission (EC) has approved

August 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.